These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 12227693

  • 21. Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort.
    Coppo R, Lofaro D, Camilla RR, Bellur S, Cattran D, Cook HT, Roberts IS, Peruzzi L, Amore A, Emma F, Fuiano L, Berg U, Topaloglu R, Bilginer Y, Gesualdo L, Polci R, Mizerska-Wasiak M, Caliskan Y, Lundberg S, Cancarini G, Geddes C, Wetzels J, Wiecek A, Durlik M, Cusinato S, Rollino C, Maggio M, Praga M, K Smerud H, Tesar V, Maixnerova D, Barratt J, Papalia T, Bonofiglio R, Mazzucco G, Giannakakis C, Soderberg M, Orhan D, Di Palma AM, Maldyk J, Ozluk Y, Sudelin B, Tardanico R, Kipgen D, Steenbergen E, Karkoszka H, Perkowska-Ptasinska A, Ferrario F, Gutierrez E, Honsova E.
    Pediatr Nephrol; 2017 Jan; 32(1):139-150. PubMed ID: 27557557
    [Abstract] [Full Text] [Related]

  • 22. Vascular diseases and their risk factors in IgA nephropathy.
    Myllymäki J, Syrjänen J, Helin H, Pasternack A, Kattainen A, Mustonen J.
    Nephrol Dial Transplant; 2006 Jul; 21(7):1876-82. PubMed ID: 16522659
    [Abstract] [Full Text] [Related]

  • 23. Angiotensin-converting enzyme insertion/deletion polymorphism and prognosis of IgA nephropathy.
    Syrjänen J, Huang XH, Mustonen J, Koivula T, Lehtimäki T, Pasternack A.
    Nephron; 2000 Oct; 86(2):115-21. PubMed ID: 11014979
    [Abstract] [Full Text] [Related]

  • 24. Copeptin, a surrogate marker for arginine vasopressin, is associated with disease severity and progression in IgA nephropathy patients.
    Zittema D, van den Brand JA, Bakker SJ, Wetzels JF, Gansevoort RT.
    Nephrol Dial Transplant; 2017 Jan 01; 32(suppl_1):i146-i153. PubMed ID: 28057871
    [Abstract] [Full Text] [Related]

  • 25. Clinicopathological features and outcomes of IgA nephropathy with hematuria and/or minimal proteinuria.
    Tan M, Li W, Zou G, Zhang C, Fang J.
    Kidney Blood Press Res; 2015 Jan 01; 40(2):200-6. PubMed ID: 25924707
    [Abstract] [Full Text] [Related]

  • 26. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy.
    Bazzi C, Rizza V, Casellato D, Stivali G, Rachele G, Napodano P, Olivieri G, Gallieni M, D'Amico G.
    J Nephrol; 2012 Jan 01; 25(5):810-8. PubMed ID: 22252844
    [Abstract] [Full Text] [Related]

  • 27. Multivariate analysis of prognostic factors and effect of treatment in patients with IgA nephropathy.
    Komatsu H, Fujimoto S, Hara S, Sato Y, Yamada K, Eto T, Nakao H.
    Ren Fail; 2005 Jan 01; 27(1):45-52. PubMed ID: 15717634
    [Abstract] [Full Text] [Related]

  • 28. Uric acid correlates with the severity of histopathological parameters in IgA nephropathy.
    Myllymäki J, Honkanen T, Syrjänen J, Helin H, Rantala I, Pasternack A, Mustonen J.
    Nephrol Dial Transplant; 2005 Jan 01; 20(1):89-95. PubMed ID: 15572382
    [Abstract] [Full Text] [Related]

  • 29. Clinical features and natural history of IgA nephropathy.
    Rychlik I, Andrassy K, Waldherr R, Zuna I, Tesar V, Jancová E, Stejskalová A, Ritz E.
    Ann Med Interne (Paris); 1999 Feb 01; 150(2):117-26. PubMed ID: 10392260
    [Abstract] [Full Text] [Related]

  • 30. Insulin resistance highly associates with hypertension in IgA nephropathy.
    Eiro M, Katoh T, Sakuma Y, Sakurai K, Suzuki H, Asahi K, Watanabe K, Watanabe T.
    Clin Nephrol; 2003 Feb 01; 59(2):71-8. PubMed ID: 12608549
    [Abstract] [Full Text] [Related]

  • 31. Serum Uric Acid Level Predicts Progression of IgA Nephropathy in Females but Not in Males.
    Nagasawa Y, Yamamoto R, Shoji T, Shinzawa M, Hasuike Y, Nagatoya K, Yamauchi A, Hayashi T, Kuragano T, Moriyama T, Isaka Y, Nakanishi T.
    PLoS One; 2016 Feb 01; 11(8):e0160828. PubMed ID: 27560997
    [Abstract] [Full Text] [Related]

  • 32. The effects of cytotoxic therapy in progressive IgA nephropathy.
    Shin JH, Lee JE, Park JH, Lim S, Jang HR, Kwon GY, Huh W, Jung SH, Kim YG, Oh HY, Kim DJ.
    Ann Med; 2016 Feb 01; 48(3):171-81. PubMed ID: 27031662
    [Abstract] [Full Text] [Related]

  • 33. High serum IgA/C3 ratio better predicts a diagnosis of IgA nephropathy among primary glomerular nephropathy patients with proteinuria ≤ 1 g/d: an observational cross-sectional study.
    Gong WY, Liu M, Luo D, Liu FN, Yin LH, Li YQ, Zhang J, Peng H.
    BMC Nephrol; 2019 Apr 30; 20(1):150. PubMed ID: 31039758
    [Abstract] [Full Text] [Related]

  • 34. Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee's glomerular grading system.
    Lee HS, Lee MS, Lee SM, Lee SY, Lee ES, Lee EY, Park SY, Han JS, Kim S, Lee JS.
    Nephrol Dial Transplant; 2005 Feb 30; 20(2):342-8. PubMed ID: 15618239
    [Abstract] [Full Text] [Related]

  • 35. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
    Manno C, Torres DD, Rossini M, Pesce F, Schena FP.
    Nephrol Dial Transplant; 2009 Dec 30; 24(12):3694-701. PubMed ID: 19628647
    [Abstract] [Full Text] [Related]

  • 36. IgA Nephropathy in Children: A Multicenter Study in Poland.
    Mizerska-Wasiak M, Turczyn A, Such A, Cichoń-Kawa K, Małdyk J, Miklaszewska M, Pietrzyk J, Rybi-Szumińska A, Wasilewska A, Firszt-Adamczyk A, Stankiewicz R, Szczepańska M, Bieniaś B, Zajączkowska M, Pukajło-Marczyk A, Zwolińska D, Siniewicz-Luzeńczyk K, Tkaczyk M, Gadomska-Prokop K, Grenda R, Demkow U, Pańczyk-Tomaszewska M.
    Adv Exp Med Biol; 2016 Dec 30; 952():75-84. PubMed ID: 27573641
    [Abstract] [Full Text] [Related]

  • 37. Clinicopathological Features to Predict Progression of IgA Nephropathy with Mild Proteinuria.
    Chen D, Liu J, Duan S, Chen P, Tang L, Zhang L, Feng Z, Cai G, Wu J, Chen X.
    Kidney Blood Press Res; 2018 Dec 30; 43(2):318-328. PubMed ID: 29529608
    [Abstract] [Full Text] [Related]

  • 38. High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy.
    Rhee H, Shin N, Shin MJ, Yang BY, Kim IY, Song SH, Lee DW, Lee SB, Kwak IS, Seong EY.
    Korean J Intern Med; 2015 May 30; 30(3):354-61. PubMed ID: 25995666
    [Abstract] [Full Text] [Related]

  • 39. Effect of hematuria on the outcome of IgA nephropathy with mild proteinuria.
    Tanaka K, Moriyama T, Iwasaki C, Takei T, Nitta K.
    Clin Exp Nephrol; 2015 Oct 30; 19(5):815-21. PubMed ID: 25475403
    [Abstract] [Full Text] [Related]

  • 40. Risk factors of progressive IgA nephropathy which progress to end stage renal disease within ten years: a case-control study.
    Shu D, Xu F, Su Z, Zhang J, Chen C, Zhang J, Ding X, Lv Y, Lin H, Huang P.
    BMC Nephrol; 2017 Jan 07; 18(1):11. PubMed ID: 28061828
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.